GLSI
Greenwich LifeSciences, Inc.
+2.01 (+12.83%)17.64USD90.2K成交股數259M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 3.6M | 5.2M | 8.3M | 3.3M | 3.4M | 2.3M | 2.3M | 2.3M | 2.2M | 2.3M | 2.2M | 1.4M |
| 銷售管理費用 | 463K | 518K | 910K | 467K | 353K | 498K | 437K | 354K | 343K | 503K | 345K | 368K |
| 營業利益 | −4.0M+7% | −5.7M+107% | −8.7M+220% | −4.2M+57% | −3.8M+49% | −2.8M-2% | −2.7M+9% | −2.7M+52% | −2.5M | −2.8M | −2.5M | −1.7M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −3.9M+5% | −5.7M+106% | −9.2M+243% | −3.7M+42% | −3.7M+52% | −2.7M-0% | −2.7M+12% | −2.6M+60% | −2.5M | −2.7M | −2.4M | −1.6M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.27-4% | -0.39+86% | -0.67+235% | -0.27+35% | -0.28+47% | -0.21+5% | -0.20+5% | -0.20+54% | -0.19 | -0.20 | -0.19 | -0.13 |
| 稀釋股數 | 14.6M | 14.6M | 13.5M | 13.6M | 13.4M | 13.2M | 13.1M | 12.9M | 12.9M | 12.8M | 12.8M | 12.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 8.9M | 10.5M | 6.2M | 3.8M | 3.1M | 2.7M | 5.8M | 7.2M | 5.5M | 7.0M | 9.1M | 10.9M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 8.9M | 10.5M | 6.2M | 3.8M | 3.1M | 2.8M | 5.8M | 7.2M | 5.5M | 7.0M | 9.1M | 11.0M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 5.8M | 5.2M | 5.8M | 2.0M | 2.5M | 2.6M | 842K | 1.4M | 390K | 294K | 297K | 302K |
| 股東權益 | 3.1M | 5.3M | 353K | 2.2M | 604K | 200K | 5.0M | 5.9M | 5.1M | 6.7M | 8.9M | 10.6M |
| 負債比 | 64.9% | 49.8% | 94.3% | 53.0% | 80.7% | 92.7% | 14.5% | 18.7% | 7.1% | 4.2% | 3.2% | 2.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −4.7M+156% | – | – | – | −1.8M | – | – | −1.8M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −19.4M | –% | -1.43 | – |
| FY2024 | – | – | −17.4M | –% | -1.34 | – |
| FY2023 | – | – | −8.9M | –% | -0.69 | – |
| FY2022 | – | – | −7.8M | –% | -0.61 | – |
| FY2021 | – | – | −4.6M | –% | -0.35 | – |
| FY2020 | – | – | −1.9M | –% | -0.20 | – |
| FY2019 | – | – | −3.4M | –% | -1.52 | – |